Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    AB8939

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AB Science To Host Virtual Conference On AB8939 Phase 1 Study
    AB Science To Host Virtual Conference On AB8939 Phase 1 Study

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3165893/0/en/AB-Science-will-hold-a-virtual-conference-on-Thursday-October-16-2025-from-2pm-to-3pm-CET-to-provide-an-update-on-the-Phase-1-study-with-AB8939.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share
    AB Science Wins EU Nod for Ph I/II AML Study With AB8939
    AB Science Wins EU Nod for Ph I/II AML Study With AB8939

    30 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/30/3123754/0/en/AB-Science-receives-regulatory-approval-from-European-countries-to-initiate-third-stage-of-Phase-I-II-study-combining-its-molecule-AB8939-with-venetoclax-for-the-treatment-of-AML.html

    GLOBENEWSWIRE
    30 Jul 2025
    Share Share